Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials
- Resource Type
- Article
- Source
- In
European Urology March 2024 85(3):293-300 - Subject
- Language
- ISSN
- 0302-2838